(18)F-FDG PET/CT for the detection of large vessel vasculitis in patients with polymyalgia rheumatica.

C Lavado-Pérez, I Martínez-Rodríguez, N Martínez-Amador, I Banzo, R Quirce, J Jiménez-Bonilla, M De Arcocha-Torres, Z Bravo-Ferrer, M Jiménez-Alonso, J L López-Defilló, R Blanco, M A González-Gay, J M Carril

Journal: Revista espanola de medicina nuclear e imagen molecular 2017;34(5):275-81

PMID: 26159505

Abstract

PURPOSE

Polymyalgia rheumatica (PMR) may present together with large vessel vasculitis (LVV), and frequently requires a more intensive therapy. The aim of the study was to evaluate the impact of (18)F-FDG PET/CT in the diagnosis and management of LVV associated to PMR.

MATERIAL AND METHODS

This prospective study included 40 consecutive patients (27 women/13 men, 68.10±10.27 years) with PMR and suspicion of associated LVV submitted for (18)F-FDG PET/CT. A PET/CT scan was obtained 180 min after (18)F-FDG intravenous injection. A visual analysis was performed on the images. Five vascular regions were evaluated: supra-aortic trunks (SAT), thoracic aorta (TA), abdominal aorta (AA), iliac arteries (IA), and femoral/tibioperoneal arteries (FTA). The intensity of uptake was graded from 0 to 3. A final diagnosis of LVV was established in 26/40 patients (65%).

RESULTS

In the 26 patients with a diagnosis of LVV, the highest intensity of (18)F-FDG uptake was observed in the TA, SAT, and FTA. All of these patients showed uptake at the TA, with grade 2 and 3 in most cases. In 4 of the 14 patients without LVV, no uptake was observed in any vascular region, and in the other 10 patients only a grade 1 uptake was observed in 1 or to 2 territories. Out of the 20 treated LVV patients, (18)F-FDG PET/CT led to a therapeutic change in 17 (85%).

CONCLUSION

(18)F-FDG PET/CT was useful in identifying patients with LVV associated to PMR. The detection of vascular inflammation had an important impact, and led to a change of treatment in a high percentage of patients with LVV.

Copyright © 2015 Elsevier España, S.L.U. and SEMNIM. All rights reserved.

Address: Department of Nuclear Medicine, Molecular Imaging Group (IDIVAL), Marqués de Valdecilla University Hospital, University of Cantabria, Santander, Spain.; Department of Nuclear Medicine, Molecular Imaging Group (IDIVAL), Marqués de Valdecilla University Hospital, University of Cantabria, Santander, Spain. Electronic address: [email protected].; Department of Rheumatology, Marqués de Valdecilla University Hospital, University of Cantabria, Santander, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.